e-Drug3D 334 |
OXANDROLONE DISCONTINUED
|
cas 53-39-4 |
CLASS METABOLISME |
ROUTE (list) ORAL |
ATC code |
PK parameters t1/2 13.3 HOUR |
Target TARGET ANDROGEN RECEPTOR |
DrugCentral Androgen receptor UNIPROT P10275 AR |
Download SDF file | (1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[7,6-h]isochromen-7-one Formula: Calculated chemical properties: MW 306.43 NB_atoms 22 XLogP 3.54 PSA 47.228 NB_HD 1 NB_HA 3 fsp3 0.95 Lipinski(0=no;1=yes) 1 |
FDA NDA 013718 (label) INN (OXANDROLONE) OXANDRIN (GEMINI LABS LLC) APPROVAL= AP YEAR= 1964 NEWMOLECULARENTITY DISCONTINUED OBSOLETE NDA 076761 (label) INN (OXANDROLONE) OXANDROLONE (UPSHER SMITH LABS) APPROVAL= AP YEAR= 2006 DISCONTINUED NDA 076897 (label) INN (OXANDROLONE) OXANDROLONE (SANDOZ) APPROVAL= AP YEAR= 2006 DISCONTINUED NDA 077249 (pdf not found) INN (OXANDROLONE) OXANDROLONE (ROXANE) APPROVAL= AP YEAR= 2007 DISCONTINUED NDA 077827 (pdf not found) INN (OXANDROLONE) OXANDROLONE (PAR PHARM) APPROVAL= AP YEAR= 2007 DISCONTINUED NDA 078033 (pdf not found) INN (OXANDROLONE) OXANDROLONE (UPSHER SMITH LABS) APPROVAL= AP YEAR= 2007 DISCONTINUED |
Other links: |